Protocol Design Featured Articles

  1. Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial 4/30/2025

    CEO and President Paul Goode, Ph.D., explores the implantable CBGM’s trial design, as well as the company’s approach to patient input, site selection, and more for its first-in-human trial.

  2. The Future of Glaucoma Therapy: Adaptive Trial Design and Patient-Centric Protocols 4/25/2025

    Perfuse Therapeutics' Sevgi Gurkan, MD, discusses the company’s use of functional and structural endpoints, exploratory biomarkers, adaptive trial design plans, and patient-centric protocol development.

  3. Track Your Trial's Carbon Footprint With This Sustainability Calculator 4/24/2025

    Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.

  4. Unsure About The New ICH Guidelines? TransCelerate Debuts 13 Tools To Help 4/23/2025

    TransCelerate BioPharma's Tashan Mistree discusses 13 new tools created alongside the Association of Clinical Research Organizations (ACRO) to support ICH GCP E6(R3) adoption.

  5. "A Long Way To Go": Patient Wants Better Listening From Pharma 4/15/2025

    Aspirin exacerbated respiratory disease (AERD) patient advocate Rhonda Nelson shares her patient experience and explains how she thinks pharma companies can better integrate the patient voice into clinical trial design. 

  6. Smart Trial Design In Cell Therapy: Fast-Tracking Without Compromising 4/10/2025

    Discover clinical trial designs and real-life examples that enable fast and safe studies in cell therapy.

  7. The Evolution Of A Clinical Research Coordinator 4/9/2025

    Briana White is a CRC with Superior Clinical Research, a small clinical research site in Smithfield NC. She talks about how she got into the clinical industry and what she struggles with in her job (spoiler alert: it involves tech). 

  8. FAQ On The Clinical Trial Process 4/4/2025

    What are clinical trials and how do they typically unfold? In this Q&A, you will learn about the four distinct clinical trial phases, participation eligibility, recruitment and more.

  9. The Early Phase Australian Advantage For Biotech Companies 4/4/2025

    Australia's clinical landscape presents a compelling environment for early-phase clinical trials, characterized by regulatory efficiency and cost-effectiveness.

  10. Feasibility/Site Selection Process Ripe For Improvement 4/1/2025

    One key to a more effective feasibility process is more transparent communications and collaboration between sponsors, CROs, and sites. Sponsors must provide clear information to each site to enable a more accurate recruitment assessment, and sites must properly digest the information to give an accurate projection. But how?